Data incorporated for this study were collected from 9 centers in the UK focused on third-line and beyond chimeric antigen ...

Ten years of substantial work by Université de Montréal immunologist Nathalie Labrecque's team at the Montreal Clinical ...

Clinical studies confirm that these approaches enhance efficacy and safety, though ongoing research is refining bispecific CAR structures and optimizing T-cell transduction efficiency. Researchers ...

In this article, we will discuss the mechanisms of bacterial transduction and how scientists can utilize it to manipulate bacterial genomes for a wide variety of purposes. When viruses replicate ...

ATI-2138 exhibits the ability to selectively and potently block interleukin-2-inducible T cell kinase (ITK ... a best-in-class inhibitor of key signal transduction kinases as a result of its ...

With government support and favorable reimbursement policies, the eligibility of hematologic cancer patients for CAR T-cell therapy increased from 2.7% in 2017 to 3.9% in 2023. Additionally ...